DHX35

Across TCGA pan-cancer cohorts, DHX35 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated DHX35 data layer compared with 24 for mass-spec protein and 8 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher DHX35 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated DHX35 expression acts as an unfavorable survival marker, although some lineages such as LSCC and CCRCC show a favorable association.

HNSC, LSCC, and CCRCC are the cancer types where DHX35 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	III,IV	0.347	1.000	.027	15	view →
LSCC	DFS	Median	II,III,IV	0.886	0.651	.003	11	view →
CCRCC	DFS	Median	All	0.873	0.727	.037	4	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

DHX35–HNSC (OS)

Open the HNSC breakdown →